- It’s a first Pan-India 1000 Genome Sequencing of SARS-CoV-2 Completed
- He reviewed the COVID-19 activities of Department of Biotechnology (DBT), Biotechnology Industry Research Assistance Council (BIRAC) and DBT-Autonomous Institutions (AIs) in the meeting with DBT.
Along with this Minister also launched the largest network of five dedicated COVID-19 Biorepositories by the DBT at
- Institute of Life Science (ILS), Bhubaneshwar
- Translational Health Science and Technology Institute (THSTI), Faridabad
- Institute of Liver and Biliary Sciences (ILBS), New Delhi
- National Centre for Cell Science (NCCS), Pune
- Institute for Stem Cell Science and Regenerative Medicine (InStem), Bangalore.
What is Pan India 1000 SARS–CoV-2 RNA Genome Sequencing programme?
- This programme was launched by the Department of Biotechnology(DBT) in May 2020.
- It was conducted by the autonomous institutes of DBT in collaboration with the national laboratories and clinical organisation.
- The consortium was coordinated by National Institute of Biomedical Genomics (NIBMG-Kalyani), West Bengal and five other National clusters, Institute of Life Science (ILS)-Bhubaneswar, Centre for DNA Fingerprinting and Diagnostics (CDFD)-Hyderabad, InStem- National Centre for Biological Sciences (NCBS) -Indian Institute of Science(IISc) -Bangalore, and National Centre for Cell Science (NCCS) – Pune are actively participating in sequencing and analysis.
The institutes and clinical organisations that are involved in the programme are include ICMR – National Institute of Cholera and Enteric Diseases,
- Institute of Postgraduate Medical Education and Research (IPGMER) – Kolkata,
- IISc – Bangalore,
- All India Institute of Medical Sciences(AIIMS) – Rishikesh, Uttarakhand,
- Maulana Azad Medical College (MAMC) – Delhi,
- THSTI – Faridabad,
- Grant Medical College (GMC) – Aurangabad,
- Mahatma Gandhi Institute of Medical Sciences (MGIMS) – Wardha,
- Armed Forces Medical College (AFMC)
